Which information is essential to collect during screening for substance use disorders?

Which information is essential to collect during screening for substance use disorders?

• A. Presenting problem, current substance use, prior treatments, medical/psychiatric history, risk factors, legal issues, and readiness for change.
• B. Only current mood and energy level.
• C. Financial history and credit score.
• D. Genetic testing results.

Answer: (A)

A comprehensive screening for substance use disorders collects a wide range of information about what has brought the person in and their substance use history, along with medical and mental health context and motivation to change. This breadth is essential because it helps determine how severe the problem is, whether there are co-occurring conditions, and what level of care and treatment approach is appropriate. Knowing the present use and past treatments informs diagnosis and prognosis, while the medical and psychiatric history highlights safety concerns and potential drug interactions. Identifying risk factors and legal issues points to relapse triggers and practical barriers, and assessing readiness for change guides how to engage the person and tailor motivational strategies. The other options miss critical areas: focusing only on mood and energy neglects substance use patterns and history; financial history isn’t directly informative for screening and treatment planning; genetic testing isn’t routinely used in initial screening and doesn’t provide the actionable context needed at this stage.

A comprehensive screening for substance use disorders collects a wide range of information about what has brought the person in and their substance use history, along with medical and mental health context and motivation to change. This breadth is essential because it helps determine how severe the problem is, whether there are co-occurring conditions, and what level of care and treatment approach is appropriate. Knowing the present use and past treatments informs diagnosis and prognosis, while the medical and psychiatric history highlights safety concerns and potential drug interactions. Identifying risk factors and legal issues points to relapse triggers and practical barriers, and assessing readiness for change guides how to engage the person and tailor motivational strategies. The other options miss critical areas: focusing only on mood and energy neglects substance use patterns and history; financial history isn’t directly informative for screening and treatment planning; genetic testing isn’t routinely used in initial screening and doesn’t provide the actionable context needed at this stage.